VPM1002 Market

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
VPM1002 Market aims to provide a comprehensive presentation of the global market for VPM1002 (Tuberculosis BCG Based Vaccine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding VPM1002 (Tuberculosis BCG Based Vaccine). VPM1002 Market contains market size and forecasts of VPM1002 (Tuberculosis BCG Based Vaccine) in global, including the following market information:
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five VPM1002 (Tuberculosis BCG Based Vaccine) companies in 2022 (%)
The global VPM1002 (Tuberculosis BCG Based Vaccine) market was valued at US$ 384.5 million in 2022 and is projected to reach US$ 481.1 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
We surveyed the VPM1002 (Tuberculosis BCG Based Vaccine) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Segment Percentages, by Type, 2022 (%)
by Dosage
0.5ml Package
1ml Package
2ml Package
Other
by Type of Inoculator
Initial Vaccinate
Revaccination
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Segment Percentages, by Application, 2022 (%)
0-5 Years Old
5-18 Years Old
18-45 Years Old
45-65 Years Old
?65 Years Old
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies VPM1002 (Tuberculosis BCG Based Vaccine) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies VPM1002 (Tuberculosis BCG Based Vaccine) revenues share in global market, 2022 (%)
Key companies VPM1002 (Tuberculosis BCG Based Vaccine) sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies VPM1002 (Tuberculosis BCG Based Vaccine) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Vakzine Projekt Management (VPM)
Serum Institute of India
Outline of Major Chapters:
Chapter 1: Introduces the definition of VPM1002 (Tuberculosis BCG Based Vaccine), market overview.
Chapter 2: Global VPM1002 (Tuberculosis BCG Based Vaccine) market size in revenue and volume.
Chapter 3: Detailed analysis of VPM1002 (Tuberculosis BCG Based Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of VPM1002 (Tuberculosis BCG Based Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global VPM1002 (Tuberculosis BCG Based Vaccine) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.